VENXXIVA
NDC 70709-121, tiopronin, tablet, delayed release, from Cycle Pharmaceuticals Ltd..
- Product NDC
- 70709-121
- Status
- Listed
- Labeler
- Cycle Pharmaceuticals Ltd.
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216990
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70709-121 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TIOPRONIN100 mg/1
Pharmacologic classes
Cystine Disulfide Reduction [MoA]; N-substituted Glycines [CS]; Reducing and Complexing Thiol [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70709-121-30 | 70709012130 | 300 TABLET, DELAYED RELEASE in 1 BOTTLE (70709-121-30) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/02e24443-04c6-4b98-a395-49aec4a468de
Use it
Look up 70709-121 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70709-121 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70709-121. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.